The familial Parkinson Disease gene PARK2 is a multisite tumor suppressor on chromosome 6q25.2-27 that regulates cyclin E

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cell Cycle

• Publication date

  2010-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cc.9.8.11583PMID 20372088PMCID PMC2921461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Cyclin E deregulation is an early event in the development of breast cancer

  2009cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer

  2007cited by this paper
• Parkin-associated Parkinson’s disease

  2004cited by this paper
• Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.

  2003cited by this paper
• Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27

  2003cited by this paper
• Association between early-onset Parkinson's disease and mutations in the parkin gene.

  2000cited by this paper
• Deregulated cyclin E induces chromosome instability

  1999cited by this paper

• Genetically encoded and modular subcellular organelle probes reveal dysfunction in lysosomes and mitochondria driven by PRKN knockout

  2025cites this paper
• Genetically Encoded and Modular SubCellular Organelle Probes (GEM-SCOPe) reveal lysosomal and mitochondrial dysfunction driven by PRKN knockout

  2024cites this paper
• Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers

  2023cites this paper
• Triaging between post-translational modification of cell cycle regulators and their therapeutics in neurodegenerative diseases.

  2023cites this paper
• Application of codon usage and context analysis in genes up- or down-regulated in neurodegeneration and cancer to combat comorbidities

  2023cites this paper
• Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities

  2022cites this paper
• Parkin and its molecular associations in gliomas – a systematic review

  2021cites this paper
• Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division.

  2021cites this paper
• Parkin: A targetable linchpin in human malignancies.

  2021cites this paper
• Autophagy and Hallmarks of Cancer.

  2018cites this paper
• Parkin in Parkinson’s Disease and Cancer: a Double-Edged Sword

  2018cites this paper
• Mechanisms, pathophysiological roles and methods for analyzing mitophagy – recent insights

  2018cites this paper
• Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients

  2017cites this paper
• Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients

  2017cites this paper
• Parkin-Independent Mitophagy Controls Chemotherapeutic Response in Cancer Cells.

  2017cites this paper
• RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.

  2016cites this paper
• Role of the Cell Cycle Re-Initiation in DNA Damage Response of Post-Mitotic Cells and Its Implication in the Pathogenesis of Neurodegenerative Diseases

  2016influential citation
• Tumor Suppressor Genes within Common Fragile Sites Are Active Players in the DNA Damage Response

  2016cites this paper
• Melatonin‐induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy

  2016cites this paper
• Parkin New Cargos: a New ROS Independent Role for Parkin in Regulating Cell Division.

  2016cites this paper
• Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases

  2015cites this paper
• Functions and characteristics of PINK1 and Parkin in cancer.

  2015cites this paper
• Pathologic and therapeutic implications for the cell biology of parkin.

  2015cites this paper
• NGF/P75 in Cell Cycle and Tetraploidy

  2014cites this paper
• RBR E3‐ligases at work

  2014cites this paper
• Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins

  2014cites this paper
• Inhibition Functions and characteristics of PINK 1 and Parkin in cancer

  2014cites this paper
• Variety, complexity, specificity… infinitively seductive ubiquitin

  2013cites this paper
• Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease

  2013cites this paper
• Cross‐functional E3 ligases Parkin and C‐terminus Hsp70‐interacting protein in neurodegenerative disorders

  2012cites this paper
• Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death

  2012cites this paper
• Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?

  2012cites this paper
• The Interfaces Between Signal Transduction Pathways: IGF-1/mTor, p53 and the Parkinson Disease Pathway

  2012cites this paper
• The ubiquitin-proteasome system in glioma cell cycle control

  2012cites this paper
• Cancer and Neurodegeneration: Between the Devil and the Deep Blue Sea

  2010cites this paper
• Leprosy and the Human Genome

  2010cites this paper